{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:54:56Z","timestamp":1783976096975,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Low-density lipoprotein receptor (\n                      <jats:italic>LDLR<\/jats:italic>\n                      ) and scavenger receptor class B member 1 (\n                      <jats:italic>SCARB1<\/jats:italic>\n                      ) are essential regulators of systemic lipid homeostasis. Although dysregulated lipid metabolism is a hallmark of malignancy, the genetic associations between these receptors and the risks of hepatocellular carcinoma (HCC) remain poorly understood. This study aimed to evaluate the impacts of\n                      <jats:italic>LDLR<\/jats:italic>\n                      and\n                      <jats:italic>SCARB1<\/jats:italic>\n                      polymorphisms on the susceptibility to HCC and clinical biochemical profiles in a population with a high prevalence of viral hepatitis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this case\u2012control study, 81 HCC patients and 162 healthy controls were genotyped for the\n                      <jats:italic>SCARB1<\/jats:italic>\n                      rs4238001 and\n                      <jats:italic>LDLR<\/jats:italic>\n                      rs688 and rs5925 variants by using an automated capillary electrophoresis system. The correlations between the genetic data and clinical markers of liver injury, including alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, as well as low-density lipoprotein cholesterol (LDL-C) levels, were evaluated. Statistical analyses used logistic regression for risk estimation and nonparametric tests (medians and interquartile ranges) for biochemical correlations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>LDLR<\/jats:italic>\n                      rs5925 polymorphism emerged as a major risk factor for HCC. According to the recessive model, compared with the reference genotypes, the homozygous CC genotype was associated with a 13.05-fold greater risk of HCC [Odds ratios (OR)\u2009=\u200913.05, 95% CI: 3.69\u201346.12;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001]. According to the dominant model, carriers of the minor C allele had a 6.94-fold increased risk of HCC (OR\u2009=\u20096.94, 95% CI: 3.82\u201312.60;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Additionally, the\n                      <jats:italic>LDLR<\/jats:italic>\n                      rs688 variant was linked to metabolic alterations, with the TT homozygotes having significantly higher LDL-C levels (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.025) and the CT heterozygotes having elevated ALT levels (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002). Notably, the rs5925 CC genotype strongly correlated with elevated AST levels (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.022), which suggested a synergistic link between genetic predisposition and hepatocellular injury. Building on these findings, we conducted an interaction analysis, which supported an integrated \u2018double-hit\u2019 model, demonstrating for the first time how the synergy between\n                      <jats:italic>LDLR<\/jats:italic>\n                      and\n                      <jats:italic>SCARB1<\/jats:italic>\n                      polymorphisms modulates the HCC risk through disrupted lipid homeostasis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The findings demonstrate that the\n                      <jats:italic>LDLR<\/jats:italic>\n                      rs5925 variant is a potent genetic marker for susceptibility to HCC. The association of\n                      <jats:italic>LDLR<\/jats:italic>\n                      variants with impaired lipid homeostasis and hepatic stress supports a \u2018double-hit\u2019 model in which genetic vulnerability and chronic viral hepatitis factors synergistically promote hepatocarcinogenesis. These results highlight the potential utility of genetic screening for personalized risk stratification of patients with chronic liver disease.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12944-026-02946-x","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T10:36:16Z","timestamp":1775903776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of LDLR and SCARB1 gene polymorphisms with hepatocellular carcinoma: a case-control study proposing a \u2018double-hit\u2019 model"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9805-6624","authenticated-orcid":false,"given":"Zuhal","family":"Altintas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muammer Ozgur","family":"Cevik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Derici Eker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engin","family":"Altintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"issue":"1","key":"2946_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of Hepatocellular Carcinoma. Hepatology. 2021;73(1):4\u201313. https:\/\/doi.org\/10.1002\/hep.31288. Epub 2020 Nov 24. PMID: 32319693; PMCID: PMC7577946.","journal-title":"Hepatology"},{"issue":"12","key":"2946_CR2","doi-asserted-by":"publisher","first-page":"101571","DOI":"10.1016\/j.jhepr.2025.101571","volume":"7","author":"E Mauro","year":"2025","unstructured":"Mauro E, de Castro T, Zeitlhoefler M, Sung MW, Villanueva A, Mazzaferro V, Llovet JM. Hepatocellular carcinoma: Epidemiology, diagnosis and treatment. JHEP Rep. 2025;7(12):101571. https:\/\/doi.org\/10.1016\/j.jhepr.2025.101571. PMID: 41244300; PMCID: PMC12615749.","journal-title":"JHEP Rep"},{"issue":"4","key":"2946_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","volume":"21","author":"J Luo","year":"2020","unstructured":"Luo J, Yang H, Song BL. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020;21(4):225\u201345. https:\/\/doi.org\/10.1038\/s41580-019-0190-7. Epub 2019 Dec 17. PMID: 31848472.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2946_CR4","doi-asserted-by":"publisher","first-page":"762828","DOI":"10.3389\/fcell.2021.762828","volume":"9","author":"F Zhou","year":"2021","unstructured":"Zhou F, Sun X. Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma. Front Cell Dev Biol. 2021;9:762828. https:\/\/doi.org\/10.3389\/fcell.2021.762828. PMID: 34869352; PMCID: PMC8635701.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"2946_CR5","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jhep.2012.11.014","volume":"58","author":"SM Walenbergh","year":"2013","unstructured":"Walenbergh SM, Koek GH, Bieghs V, Shiri-Sverdlov R. Non-alcoholic steatohepatitis: the role of oxidized low-density lipoproteins. J Hepatol. 2013;58(4):801\u201310. https:\/\/doi.org\/10.1016\/j.jhep.2012.11.014. Epub 2012 Nov 23. PMID: 23183522.","journal-title":"J Hepatol"},{"key":"2946_CR6","doi-asserted-by":"publisher","first-page":"101230","DOI":"10.1016\/j.molmet.2021.101230","volume":"51","author":"Z Chen","year":"2021","unstructured":"Chen Z, Chen L, Sun B, Liu D, He Y, Qi L, Li G, Han Z, Zhan L, Zhang S, Zhu K, Luo Y, Chen L, Zhang N, Guo H. LDLR inhibition promotes hepatocellular carcinoma proliferation and metastasis by elevating intracellular cholesterol synthesis through the MEK\/ERK signaling pathway. Mol Metab. 2021;51:101230. Epub 2021 Apr 3. PMID: 33823318; PMCID: PMC8102998.","journal-title":"Mol Metab"},{"issue":"2","key":"2946_CR7","doi-asserted-by":"publisher","first-page":"e23646","DOI":"10.1002\/jbt.23646","volume":"38","author":"S Zhu","year":"2024","unstructured":"Zhu S, Cao S, Che J, Zhao L, Su Z, Li D, Pei R, Xu L, Ding Y, Zhou W. SCARB1-encoded circ _0029343 induces p73 splicing to promote growth and metastasis of hepatocellular carcinoma via miR-486-5p\/SRSF3 axis. J Biochem Mol Toxicol. 2024;38(2):e23646. https:\/\/doi.org\/10.1002\/jbt.23646. PMID: 38345168.","journal-title":"J Biochem Mol Toxicol"},{"issue":"2","key":"2946_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2017.03.020","volume":"67","author":"S von Westhaus","year":"2017","unstructured":"Westhaus S, Deest M, Nguyen ATX, Stanke F, Heckl D, Costa R, Schambach A, Manns MP, Berg T, Vondran FWR, Sarrazin C, Ciesek S, von Hahn T. Scavenger receptor class B member 1 (SCARB1) variants modulate hepatitis C virus replication cycle and viral load. J Hepatol. 2017;67(2):237\u201345 https:\/\/doi.org\/10.1016\/j.jhep.2017.03.020. Epub 2017 Mar 29. PMID: 2836379.","journal-title":"J Hepatol"},{"key":"2946_CR9","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.2147\/CMAR.S304125","volume":"13","author":"S Zhu","year":"2021","unstructured":"Zhu S, Cao S, Yang W, Che J, Li D, Pei R, Ding Y. The Maturation of Tumor Suppressor miR-497 in Hepatocellular Carcinoma is Inhibited by Oncogenic circRNA SCARB1. Cancer Manag Res. 2021;13:5751\u20139. PMID: 34305409; PMCID: PMC8292958.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"2946_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12944-017-0488-4","volume":"16","author":"CS Paththinige","year":"2017","unstructured":"Paththinige CS, Sirisena ND, Dissanayake V. Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review. Lipids Health Dis. 2017;16(1):103. https:\/\/doi.org\/10.1186\/s12944-017-0488-4. PMID: 28577571; PMCID: PMC5457620.","journal-title":"Lipids Health Dis"},{"issue":"4","key":"2946_CR11","first-page":"2599","volume":"22","author":"B Ma","year":"2020","unstructured":"Ma B, Jia J, Wang X, Zhang R, Niu S, Ni L, Di X, Liu C. Differential roles of Scavenger receptor class B type I: A protective molecule and a facilitator of atherosclerosis (Review). Mol Med Rep. 2020;22(4):2599\u2013604. Epub 2020 Jul 28. PMID: 32945418; PMCID: PMC7453654.","journal-title":"Mol Med Rep"},{"issue":"2","key":"2946_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","volume":"82","author":"European Association for the Study of the Liver","year":"2025","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma. J Hepatol. 2025;82(2):315\u201374. https:\/\/doi.org\/10.1016\/j.jhep.2024.08.028. Epub 2024 Dec 17. PMID: 39690085.","journal-title":"J Hepatol"},{"key":"2946_CR13","doi-asserted-by":"publisher","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-4. https:\/\/doi.org\/10.1001\/jama.2013.281053. PMID: 24141714.","DOI":"10.1001\/jama.2013.281053"},{"issue":"1","key":"2946_CR14","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1186\/s40001-023-01547-z","volume":"28","author":"D Cao","year":"2023","unstructured":"Cao D, Liu H. Dysregulated cholesterol regulatory genes in hepatocellular carcinoma. Eur J Med Res. 2023;28(1):580. https:\/\/doi.org\/10.1186\/s40001-023-01547-z. PMID: 38071335; PMCID: PMC10710719.","journal-title":"Eur J Med Res"},{"issue":"14","key":"2946_CR15","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1093\/hmg\/ddm124","volume":"16","author":"H Zhu","year":"2007","unstructured":"Zhu H, Tucker HM, Grear KE, Simpson JF, Manning AK, Cupples LA, Estus S. A common polymorphism decreases low-density lipoprotein receptor exon 12 splicing efficiency and associates with increased cholesterol. Hum Mol Genet. 2007;16(14):1765\u201372. https:\/\/doi.org\/10.1093\/hmg\/ddm124. Epub 2007 May 21. PMID: 17517690; PMCID: PMC2361133.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"2946_CR16","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1093\/hmg\/dds559","volume":"22","author":"F Gao","year":"2013","unstructured":"Gao F, Ihn HE, Medina MW, Krauss RM. A common polymorphism in the LDL receptor gene has multiple effects on LDL receptor function. Hum Mol Genet. 2013;22(7):1424\u201331. https:\/\/doi.org\/10.1093\/hmg\/dds559. Epub 2013 Jan 7. PMID: 23297366; PMCID: PMC3596853.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2946_CR17","doi-asserted-by":"publisher","first-page":"102529","DOI":"10.1016\/j.clinre.2025.102529","volume":"49","author":"A Borgne-Sanchez","year":"2025","unstructured":"Borgne-Sanchez A, Fromenty B. Mitochondrial dysfunction in drug-induced hepatic steatosis: Recent findings and current concept. Clin Res Hepatol Gastroenterol. 2025;49(3):102529. https:\/\/doi.org\/10.1016\/j.clinre.2025.102529. Epub 2025 Jan 9. PMID: 39798918.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2946_CR18","doi-asserted-by":"publisher","first-page":"100737","DOI":"10.1016\/j.curtheres.2024.100737","volume":"100","author":"S Thakur","year":"2024","unstructured":"Thakur S, Kumar V, Das R, Sharma V, Mehta DK. Biomarkers of Hepatic Toxicity: An Overview. Curr Ther Res Clin Exp. 2024;100:100737. https:\/\/doi.org\/10.1016\/j.curtheres.2024.100737. PMID: 38860148; PMCID: PMC11163176.","journal-title":"Curr Ther Res Clin Exp"},{"issue":"1","key":"2946_CR19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1186\/s12872-025-05113-9","volume":"25","author":"NTT Sen","year":"2025","unstructured":"Sen NTT, Nga PTN, Toan NH, Kien NT. Investigation of the characteristics of LDLR gene rs688 polymorphism and its association with dyslipidemia in patients at high to very high cardiovascular risk. BMC Cardiovasc Disord. 2025;25(1):666. https:\/\/doi.org\/10.1186\/s12872-025-05113-9. PMID: 41013249; PMCID: PMC12465651.","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"2946_CR20","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1002\/hep.27014","volume":"59","author":"CH Chiang","year":"2014","unstructured":"Chiang CH, Lee LT, Hung SH, Lin WY, Hung HF, Yang WS, Sung PK, Huang KC. Opposite association between diabetes, dyslipidemia, and hepatocellular carcinoma mortality in the middle-aged and elderly. Hepatology. 2014;59(6):2207-15. https:\/\/doi.org\/10.1002\/hep.27014. Epub 2014 Apr 3. PMID: 24425422.","journal-title":"Hepatology"},{"issue":"1","key":"2946_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41420-023-01621-9","volume":"9","author":"W Chen","year":"2023","unstructured":"Chen W, Bao L, Ren Q, Zhang Z, Yi L, Lei W, Yang Z, Lu Y, You B, You Y, Gu M. SCARB1 in extracellular vesicles promotes NPC metastasis by co-regulating M1 and M2 macrophage function. Cell Death Discov. 2023;9(1):323. https:\/\/doi.org\/10.1038\/s41420-023-01621-9. PMID: 37644041; PMCID: PMC10465564.","journal-title":"Cell Death Discov"},{"issue":"6","key":"2946_CR22","doi-asserted-by":"publisher","first-page":"626","DOI":"10.7150\/jca.13837","volume":"7","author":"SS Jiang","year":"2016","unstructured":"Jiang SS, Weng DS, Jiang L, Zhang YJ, Pan K, Pan QZ, Chen CL, Zhao JJ, Zhang XF, Zhang HX, Tang Y, Zhou ZQ, Chen MS, Xia JC. The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma. J Cancer. 2016;7(6):626\u201332. https:\/\/doi.org\/10.7150\/jca.13837. PMID: 27076843; PMCID: PMC4829548.","journal-title":"J Cancer"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-02946-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02946-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02946-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:50:23Z","timestamp":1781646623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-02946-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2946"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-02946-x","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Mersin University Ethics Committee (Protocol No: 2025\/529) and was conducted in accordance with the ethical principles of the Declaration of Helsinki. Written informed consent was obtained from all participants prior to their inclusion in the study. All procedures were performed in compliance with relevant institutional and national guidelines on human experimentation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"136"}}